Steven J Mento - Net Worth and Insider Trading
Steven J Mento Net Worth
The estimated net worth of Steven J Mento is at least $335,119 dollars as of 2024-11-13. Steven J Mento is the President, CEO & Director of Conatus Pharmaceuticals Inc and owns about 385,669 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $215,975. Steven J Mento is also the Director of Sangamo Therapeutics Inc and owns about 44,046 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $119,144. Details can be seen in Steven J Mento's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven J Mento has not made any transactions after 2018-04-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven J Mento
Steven J Mento Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven J Mento owns 3 companies in total, including Histogen Inc (HSTO) , Sangamo Therapeutics Inc (SGMO) , and Dermata Therapeutics Inc (DRMA) .
Click here to see the complete history of Steven J Mento’s form 4 insider trades.
Insider Ownership Summary of Steven J Mento
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HSTO | Histogen Inc | 2020-05-22 | director |
SGMO | Sangamo Therapeutics Inc | 2018-04-02 | director |
DRMA | Dermata Therapeutics Inc | 2021-08-12 | director |
Steven J Mento Latest Holdings Summary
Steven J Mento currently owns a total of 2 stocks. Among these stocks, Steven J Mento owns 385,669 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $215,975 and a weighting of 64.45%. Steven J Mento also owns 44,046 shares of Sangamo Therapeutics Inc (SGMO) as of April 2, 2018, with a value of $119,144 and a weighting of 35.55%.
Latest Holdings of Steven J Mento
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 385,669 | 0.56 | 215,975 |
SGMO | Sangamo Therapeutics Inc | 2018-04-02 | 44,046 | 2.71 | 119,144 |
Holding Weightings of Steven J Mento
Steven J Mento Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven J Mento has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the acquisition of 13,800 shares on July 30, 2013, which cost Steven J Mento around $151,800.
According to the SEC Form 4 filings, Steven J Mento has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 7,215 shares on April 2, 2018, which brought Steven J Mento around $132,756.
Insider Trading History of Steven J Mento
- 1
Steven J Mento Trading Performance
GuruFocus tracks the stock performance after each of Steven J Mento's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven J Mento is -2.19%. GuruFocus also compares Steven J Mento's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven J Mento within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven J Mento's insider trading performs compared to the benchmark.
Performance of Steven J Mento
Steven J Mento Ownership Network
Ownership Network List of Steven J Mento
Ownership Network Relation of Steven J Mento
Steven J Mento Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Steven J Mento is the director of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Steven J Mento Mailing Address
Above is the net worth, insider trading, and ownership report for Steven J Mento. You might contact Steven J Mento via mailing address: C/o Sangamo Biosciences, Inc., 501 Canal Blvd Suite A-100, Richmond Ca 94804.